1. Silenced LASP1 interacts with DNMT1 to promote TJP2 expression and attenuate articular cartilage injury in mice by suppressing TJP2 methylation
   Lian Ren et al, 2023, The Kaohsiung Journal of Medical Sciences CrossRef
2. MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer
   Wen-Yan Mo et al, 2022, Clinical and Translational Oncology CrossRef
3. HDAC1 participates in polycystic ovary syndrome through histone modification by regulating H19/miR-29a-3p/NLRP3-mediated granulosa cell pyroptosis
   Jiying Chen et al, 2023, Molecular and Cellular Endocrinology CrossRef
4. MicroRNAs in Tumor Endothelial Cells: Regulation, Function and Therapeutic Applications
   Yuan Gu et al, 2023, Cells CrossRef
5. High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms
   Shuqi Li et al, 2024, BMC Cancer CrossRef
6. The Role of lncRNA in the Pathogenesis of Osteosarcoma
   翔宇 许, 2023, Advances in Clinical Medicine CrossRef
7. LncRNA H19 alleviates sepsis-induced acute lung injury by regulating the miR-107/TGFBR3 axis
   Xiuling Hao et al, 2022, BMC Pulmonary Medicine CrossRef
8. Silencing Lnc-HES1-10 Inhibits Osteosarcoma Cells Proliferation, Invasive Ability, and Metastasis
   Yingchun Zhu et al, 2024, Journal of Pediatric Hematology/Oncology CrossRef
9. LncRNAs could play a vital role in osteosarcoma treatment: Inhibiting osteosarcoma progression and improving chemotherapy resistance
   Shi Xiaotong et al, 2023, Frontiers in Genetics CrossRef
10. MiR-29a-3p Inhibits Proliferation and Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells via Targeting FOXO3 and Repressing Wnt/β-Catenin Signaling in Steroid-Associated Osteonecrosis
    Changgeng Wang et al, 2022, International Journal of Stem Cells CrossRef
11. LncRNA HCG18 promotes osteosarcoma growth by enhanced aerobic glycolysis via the miR-365a-3p/PGK1 axis
    Xiaohui Pan et al, 2022, Cellular & Molecular Biology Letters CrossRef